theragenomics: drugs and genes
The Clinical Pharmacogenetics Implementation Consortium (CPIC) issues guidelines that are designed to help clinicians and patients alike to understand HOW available genetic test results should be used to optimize drug therapy, rather than WHETHER tests should be ordered. A key assumption underlying the CPIC guidelines is that clinical high-throughput and preemptive (pre-prescription) genotyping will become more widespread, and that clinicians will be faced with having patients’ genotypes available even if they have not explicitly ordered a test with a specific drug in mind.
CPIC assigns levels of pharmacogenetic evidence to pairs of genes and related drugs according to (1) PharmGKB Clinical Annotation Levels of Evidence of 1A, 1B, 2A and 2B, or (2) a PharmGKB PGx level for FDA-approved drug labels of i) “actionable pgx”, ii) “genetic testing recommended”, or iii) “genetic testing required”, or (3) based on nomination to CPIC for consideration.
thasso provides here the table below, in which links to each Guideline will take you to a webpage where you can download the guideline manuscript, supplement and any other related files. There, you will also find information about when the guideline was published and the most recent update of the guideline. Other links in the table will take you to more information on the PharmGKB website.
Updated: December 11, 2022
Gene | Drug | Drug RxNorm ID | Drug ATC IDs | Guideline | CPIC Level | CPIC Level Status | PharmGKB Level of Evidence | PGx on FDA Label | CPIC Publications (PMID) |
---|---|---|---|---|---|---|---|---|---|
HLA-B | abacavir | 190521 | J05AF06, J05AR02, J05AR13, J05AR04 | https://cpicpgx.org/guidelines/guideline-for-abacavir-and-hla-b/ | A | Final | 1A | Testing required | 24561393;22378157 |
HLA-B | allopurinol | 519 | M04AA01, M04AA51 | https://cpicpgx.org/guidelines/guideline-for-allopurinol-and-hla-b/ | A | Final | 1A | Testing recommended | 23232549;26094938 |
MT-RNR1 | amikacin | 641 | D06AX12, J01GB06, S01AA21 | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ | A | Final | 1A | 34032273 | |
CYP2C19 | amitriptyline | 704 | N06AA09, N06CA01 | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ | A | Final | 1A | 23486447;27997040 | |
CYP2D6 | amitriptyline | 704 | N06AA09, N06CA01 | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ | A | Final | 1A | Actionable PGx | 23486447;27997040 |
UGT1A1 | atazanavir | 343047 | J05AE08, J05AR15 | https://cpicpgx.org/guidelines/guideline-for-atazanavir-and-ugt1a1/ | A | Final | 1A | 26417955 | |
CYP2D6 | atomoxetine | 38400 | N06BA09 | https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/ | A | Final | 1A | Actionable PGx | 30801677 |
SLCO1B1 | atorvastatin | 83367 | C10AA05 | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ | A | Final | 1A | Informative PGx | 35152405 |
NUDT15 | azathioprine | 1256 | L04AX01 | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ | A | Final | 1A | Testing recommended | 21270794;23422873;30447069 |
TPMT | azathioprine | 1256 | L04AX01 | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ | A | Final | 1A | Testing recommended | 21270794;23422873;30447069 |
DPYD | capecitabine | 194000 | L01BC06 | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ | A | Final | 1A | Actionable PGx | 23988873;29152729 |
HLA-A | carbamazepine | 2002 | N03AF01 | https://cpicpgx.org/guidelines/guideline-for-carbamazepine-and-hla-b/ | A | Final | 1A | Actionable PGx | 23695185;29392710 |
HLA-B | carbamazepine | 2002 | N03AF01 | https://cpicpgx.org/guidelines/guideline-for-carbamazepine-and-hla-b/ | A | Final | 1A | Testing required | 23695185;29392710 |
CYP2C9 | celecoxib | 140587 | L01XX33, M01AH01 | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ | A | Final | 1A | Actionable PGx | 32189324 |
CYP2C19 | citalopram | 2556 | N06AB04 | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ | A | Final | 1A | Actionable PGx | 25974703 |
CYP2C19 | clopidogrel | 32968 | B01AC04 | https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ | A | Final | 1A | Actionable PGx | 21716271;23698643;35034351 |
CYP2D6 | codeine | 2670 | R05DA04, N02AA59, N02AA79 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | A | Final | 1A | Actionable PGx | 22205192;24458010;33387367 |
G6PD | dapsone | 3108 | D10AX05, J04BA02 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | A | Final | 4 | Actionable PGx | 36049896 |
CACNA1S | desflurane | 27340 | N01AB07 | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ | A | Final | 1A | Actionable PGx | 30499100 |
RYR1 | desflurane | 27340 | N01AB07 | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ | A | Final | 1A | Actionable PGx | 30499100 |
CYP2B6 | efavirenz | 195085 | J05AG03 | https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/ | A | Final | 1A | Actionable PGx | 31006110 |
CACNA1S | enflurane | 3920 | N01AB04 | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ | A | Final | 1A | Actionable PGx | 30499100 |
RYR1 | enflurane | 3920 | N01AB04 | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ | A | Final | 1A | Actionable PGx | 30499100 |
CYP2C19 | escitalopram | 321988 | N06AB10 | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ | A | Final | 1A | Actionable PGx | 25974703 |
DPYD | fluorouracil | 4492 | L01BC02, L01BC52 | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ | A | Final | 1A | Actionable PGx | 23988873;29152729 |
CYP2C9 | flurbiprofen | 4502 | M01AE09, M02AA19, R02AX01, S01BC04 | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ | A | Final | 1A | Actionable PGx | 32189324 |
CYP2C9 | fluvastatin | 41127 | C10AA04 | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ | A | Final | 1A | 35152405 | |
SLCO1B1 | fluvastatin | 41127 | C10AA04 | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ | A | Final | 1A | 35152405 | |
CYP2C9 | fosphenytoin | 72236 | N03AB05 | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ | A | Final | Actionable PGx | 25099164;32779747 | |
HLA-B | fosphenytoin | 72236 | N03AB05 | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ | A | Final | Actionable PGx | 25099164;32779747 | |
MT-RNR1 | gentamicin | D06AX07, J01GB03, S01AA11, S02AA14, S03AA06 | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ | A | Final | 1A | 34032273 | ||
CACNA1S | halothane | 5095 | N01AB01 | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ | A | Final | 1A | 30499100 | |
RYR1 | halothane | 5095 | N01AB01 | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ | A | Final | 1A | 30499100 | |
CYP2C9 | ibuprofen | 5640 | C01EB16, G02CC01, M01AE01, M02AA13 | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ | A | Final | 1A | 32189324 | |
UGT1A1 | irinotecan | 51499 | L01XX19 | A | Provisional | 1A | Actionable PGx | ||
CACNA1S | isoflurane | 6026 | N01AB06 | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ | A | Final | 1A | Actionable PGx | 30499100 |
RYR1 | isoflurane | 6026 | N01AB06 | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ | A | Final | 1A | Actionable PGx | 30499100 |
CFTR | ivacaftor | 1243041 | R07AX02, R07AX30 | https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/ | A | Final | 1A | Testing required | 24598717 |
MT-RNR1 | kanamycin | 6099 | A07AA08, J01GB04, S01AA24 | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ | A | Final | 1A | 34032273 | |
CYP2C19 | lansoprazole | 17128 | A02BC03 | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ | A | Final | 1A | Informative PGx | 32770672 |
CYP2C9 | lornoxicam | 20890 | M01AC05 | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ | A | Final | 1A | 32189324 | |
SLCO1B1 | lovastatin | 6472 | C10AA02 | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ | A | Final | 1A | 35152405 | |
CYP2C9 | meloxicam | 41493 | M01AC06 | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ | A | Final | 1A | Actionable PGx | 32189324 |
NUDT15 | mercaptopurine | 103 | L01BB02 | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ | A | Final | 1A | Testing recommended | 21270794;23422873;30447069 |
TPMT | mercaptopurine | 103 | L01BB02 | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ | A | Final | 1A | Testing recommended | 21270794;23422873;30447069 |
CACNA1S | methoxyflurane | 6857 | N02BG09 | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ | A | Final | 1A | 30499100 | |
RYR1 | methoxyflurane | 6857 | N02BG09 | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ | A | Final | 1A | 30499100 | |
G6PD | methylene blue | 6878 | NA | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | A | Final | 3 | Actionable PGx | 36049896 |
G6PD | nitrofurantoin | 7454 | J01XE01 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | A | Final | 3 | Actionable PGx | 36049896 |
CYP2D6 | nortriptyline | 7531 | N06AA10 | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ | A | Final | 1A | Actionable PGx | 23486447;27997040 |
CYP2C19 | omeprazole | 7646 | A02BC01 | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ | A | Final | 1A | Actionable PGx | 32770672 |
CYP2D6 | ondansetron | 26225 | A04AA01 | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ | A | Final | 1A | Informative PGx | 28002639 |
HLA-B | oxcarbazepine | 32624 | N03AF02 | https://cpicpgx.org/guidelines/guideline-for-carbamazepine-and-hla-b/ | A | Final | 1A | Testing recommended | 29392710 |
CYP2C19 | pantoprazole | 40790 | A02BC02 | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ | A | Final | 1A | Actionable PGx | 32770672 |
MT-RNR1 | paromomycin | 7934 | A07AA06 | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ | A | Final | 34032273 | ||
CYP2D6 | paroxetine | 32937 | N06AB05 | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ | A | Final | 1A | Informative PGx | 25974703 |
IFNL3 | peginterferon alfa-2a | 120608 | L03AB11, L03AB61 | https://cpicpgx.org/guidelines/guideline-for-peg-interferon-alpha-based-regimens-and-ifnl3/ | A | Final | 1A | 24096968 | |
IFNL4 | peginterferon alfa-2a | 120608 | L03AB11, L03AB61 | https://cpicpgx.org/guidelines/guideline-for-peg-interferon-alpha-based-regimens-and-ifnl3/ | A | Final | 1A | ||
IFNL3 | peginterferon alfa-2b | 253453 | L03AB10, L03AB60 | https://cpicpgx.org/guidelines/guideline-for-peg-interferon-alpha-based-regimens-and-ifnl3/ | A | Final | 1A | Actionable PGx | 24096968 |
IFNL4 | peginterferon alfa-2b | 253453 | L03AB10, L03AB60 | https://cpicpgx.org/guidelines/guideline-for-peg-interferon-alpha-based-regimens-and-ifnl3/ | A | Final | 1A | ||
G6PD | pegloticase | 1011650 | NA | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | A | Final | 3 | Testing required | 36049896 |
CYP2C9 | phenytoin | 8183 | N03AB02, N03AB52 | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ | A | Final | 1A | Actionable PGx | 25099164;32779747 |
HLA-B | phenytoin | 8183 | N03AB02, N03AB52 | https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/ | A | Final | 1A | Actionable PGx | 25099164;32779747 |
CYP2C9 | piroxicam | 8356 | M01AC01 | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ | A | Final | 1A | Actionable PGx | 32189324 |
SLCO1B1 | pitavastatin | 861634 | C10AA08 | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ | A | Final | 1A | 35152405 | |
CYP2D6 | pitolisant | 2197878 | N07XX11 | A | Provisional | Actionable PGx | |||
MT-RNR1 | plazomicin | 2049549 | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ | A | Final | 34032273 | |||
SLCO1B1 | pravastatin | 42463 | C10AA03 | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ | A | Final | 1A | 35152405 | |
G6PD | primaquine | 8687 | P01BA03 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | A | Final | 3 | Testing required | 36049896 |
G6PD | rasburicase | 283821 | M04AX01, V03AF07 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | A | Final | 1A | Testing required | 24787449;36049896 |
ABCG2 | rosuvastatin | 301542 | C10AA07 | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ | A | Final | 1A | 35152405 | |
SLCO1B1 | rosuvastatin | 301542 | C10AA07 | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ | A | Final | 1A | Actionable PGx | 35152405 |
CACNA1S | sevoflurane | 36453 | N01AB08 | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ | A | Final | 1A | Actionable PGx | 30499100 |
RYR1 | sevoflurane | 36453 | N01AB08 | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ | A | Final | 1A | Actionable PGx | 30499100 |
SLCO1B1 | simvastatin | 36567 | C10AA01, C10BA02, C10BX04, A10BH51, C10BA04, C10BX01 | https://cpicpgx.org/guidelines/cpic-guideline-for-statins/ | A | Final | 1A | Informative PGx | 22617227;24918167;35152405 |
CYP2C9 | siponimod | 2121085 | A | Provisional | 1A | Testing required | |||
MT-RNR1 | streptomycin | 10109 | A07AA04, J01GA01 | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ | A | Final | 1A | 34032273 | |
CACNA1S | succinylcholine | 10154 | M03AB01 | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ | A | Final | 1A | Actionable PGx | 30499100 |
RYR1 | succinylcholine | 10154 | M03AB01 | https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/ | A | Final | 1A | Actionable PGx | 30499100 |
CYP3A5 | tacrolimus | 42316 | D11AH01, L04AD02 | https://cpicpgx.org/guidelines/guideline-for-tacrolimus-and-cyp3a5/ | A | Final | 1A | 25801146 | |
G6PD | tafenoquine | 2054023 | P01BA07 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | A | Final | Testing required | 36049896 | |
CYP2D6 | tamoxifen | 10324 | L02BA01 | https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/ | A | Final | 1A | Actionable PGx | 29385237 |
CYP2C9 | tenoxicam | 37790 | M01AC02 | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ | A | Final | 1A | 32189324 | |
NUDT15 | thioguanine | 10485 | L01BB03 | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ | A | Final | 3 | Testing recommended | 21270794;23422873;30447069 |
TPMT | thioguanine | 10485 | L01BB03 | https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/ | A | Final | 3 | Testing recommended | 21270794;23422873;30447069 |
MT-RNR1 | tobramycin | 10627 | J01GB01, S01AA12 | https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/ | A | Final | 1A | 34032273 | |
G6PD | toluidine blue | 10638 | NA | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | A | Final | 36049896 | ||
CYP2D6 | tramadol | 10689 | N02AX02 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | A | Final | 1A | Actionable PGx | 33387367 |
CYP2D6 | tropisetron | 27392 | A04AA03 | https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/ | A | Final | 1A | 28002639 | |
CYP2C19 | voriconazole | 121243 | J02AC03 | https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ | A | Final | 1A | Actionable PGx | 27981572 |
CYP2C9 | warfarin | 11289 | B01AA03 | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ | A | Final | 1A | Actionable PGx | 21900891;28198005 |
CYP4F2 | warfarin | 11289 | B01AA03 | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ | A | Final | 1A | 21900891;28198005 | |
VKORC1 | warfarin | 11289 | B01AA03 | https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/ | A | Final | 1A | Actionable PGx | 21900891;28198005 |
POLG | divalproex sodium | 266856 | A/B | Provisional | Testing required | ||||
CYP2D6 | eliglustat | 1547220 | A/B | Provisional | Testing required | ||||
NAT2 | hydralazine | 5470 | C02DB02 | A/B | Provisional | 3 | |||
CYP2D6 | oliceridine | 2392230 | A/B | Provisional | Actionable PGx | ||||
CYP2D6 | pimozide | 8331 | N05AG02 | A/B | Provisional | Testing required | |||
CYP2D6 | tetrabenazine | 10390 | N07XX06 | A/B | Provisional | Testing required | |||
POLG | valproic acid | 11118 | N03AG01 | A/B | Provisional | 3 | Testing required | ||
GBA | velaglucerase alfa | 901805 | A/B | Provisional | Testing required | ||||
CYP2D6 | venlafaxine | 39786 | N06AX16 | A/B | Provisional | 1A | Actionable PGx | ||
CYP2D6 | vortioxetine | 1455099 | N06AX26 | A/B | Provisional | 3 | Actionable PGx | ||
CYP2C9 | acenocoumarol | 154 | B01AA07 | B | Provisional | 1B | |||
CYP4F2 | acenocoumarol | 154 | B01AA07 | B | Provisional | 2A | |||
CYP2D6 | aripiprazole | 89013 | N05AX12 | B | Provisional | 1A | Actionable PGx | ||
UGT1A1 | belinostat | 1543543 | B | Provisional | Actionable PGx | ||||
CYP2C19 | brivaracetam | 1739745 | B | Provisional | 3 | Actionable PGx | |||
SCN1A | carbamazepine | 2002 | N03AF01 | B | Provisional | 2B | |||
NAGS | carglumic acid | 401713 | A16AA05 | B | Provisional | Testing required | |||
CYP2C19 | clomipramine | 2597 | N06AA04 | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ | B | Final | 1A | 23486447;27997040 | |
CYP2D6 | clomipramine | 2597 | N06AA04 | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ | B | Final | 1A | Actionable PGx | 23486447;27997040 |
CYP2D6 | desipramine | 3247 | N06AA01 | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ | B | Final | 1A | Actionable PGx | 23486447;27997040 |
CYP2C19 | dexlansoprazole | 816346 | A02BC06 | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ | B | Final | 1A | Actionable PGx | 32770672 |
CYP2C19 | doxepin | 3638 | N06AA12 | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ | B | Final | 1A | Actionable PGx | 23486447;27997040 |
CYP2D6 | doxepin | 3638 | N06AA12 | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ | B | Final | 1A | Actionable PGx | 23486447;27997040 |
CYP2D6 | fluvoxamine | 42355 | N06AB08 | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ | B | Final | 1A | Actionable PGx | 25974703 |
CYP2D6 | hydrocodone | 5489 | R05DA03 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | B | Final | 1A | 33387367 | |
CYP2C19 | imipramine | 5691 | N06AA02 | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ | B | Final | 1A | 23486447;27997040 | |
CYP2D6 | imipramine | 5691 | N06AA02 | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ | B | Final | 1A | Actionable PGx | 23486447;27997040 |
CYP2B6 | methadone | 6813 | N07BC02 | B | Provisional | 2A | |||
HPRT1 | mycophenolic acid | 7145 | L04AA06 | B | Provisional | Actionable PGx | |||
CYP4F2 | phenprocoumon | 8150 | B01AA04 | B | Provisional | 3 | |||
SCN1A | phenytoin | 8183 | N03AB02, N03AB52 | B | Provisional | 3 | |||
CYP2D6 | risperidone | 35636 | N05AX08 | B | Provisional | 1A | Informative PGx | ||
CYP2C19 | sertraline | 36437 | N06AB06 | https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ | B | Final | 1A | 25974703 | |
CYP2C19 | trimipramine | 10834 | N06AA06 | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ | B | Final | 1A | 23486447;27997040 | |
CYP2D6 | trimipramine | 10834 | N06AA06 | https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/ | B | Final | 1A | Actionable PGx | 23486447;27997040 |
ABL2 | valproic acid | 11118 | N03AG01 | B | Provisional | ||||
ASL | valproic acid | 11118 | N03AG01 | B | Provisional | ||||
ASS1 | valproic acid | 11118 | N03AG01 | B | Provisional | ||||
CPS1 | valproic acid | 11118 | N03AG01 | B | Provisional | ||||
NAGS | valproic acid | 11118 | N03AG01 | B | Provisional | ||||
OTC | valproic acid | 11118 | N03AG01 | B | Provisional | Actionable PGx | |||
HLA-A | allopurinol | 519 | M04AA01, M04AA51 | B/C | Provisional | 2B | |||
NAT2 | amifampridine | 2106338 | N07XX05 | B/C | Provisional | Actionable PGx | |||
NAT2 | amifampridine phosphate | 2106337 | B/C | Provisional | Actionable PGx | ||||
CYP2D6 | amoxapine | 722 | N06AA17 | B/C | Provisional | Actionable PGx | |||
CYP2D6 | amphetamine | 725 | N06BA01 | B/C | Provisional | Informative PGx | |||
CYP2D6 | aripiprazole lauroxil | 1673265 | B/C | Provisional | Actionable PGx | ||||
ADRB1 | atenolol | 1202 | C07AB03 | B/C | Provisional | ||||
GRK5 | atenolol | 1202 | C07AB03 | B/C | Provisional | ||||
CYP2C9 | avatrombopag | 2045726 | B02BX08 | B/C | Provisional | Informative PGx | |||
CYP2D6 | brexpiprazole | 1658314 | B/C | Provisional | Actionable PGx | ||||
ADRB1 | bucindolol | B/C | Provisional | 3 | |||||
CYP2B6 | bupropion | 42347 | N06AX12 | B/C | Provisional | 2A | |||
CYP2C19 | carisoprodol | 2101 | M03BA02 | B/C | Provisional | 4 | Actionable PGx | ||
ADRB1 | carvedilol | 20352 | C07AG02 | B/C | Provisional | 3 | |||
CYP2D6 | carvedilol | 20352 | C07AG02 | B/C | Provisional | 3 | Actionable PGx | ||
GRK5 | carvedilol | 20352 | C07AG02 | B/C | Provisional | ||||
CYP2D6 | cevimeline | 44281 | N07AX03 | B/C | Provisional | Actionable PGx | |||
SLC6A4 | citalopram | 2556 | N06AB04 | B/C | Provisional | 3 | |||
CYP2C19 | clobazam | 21241 | N05BA09 | B/C | Provisional | 3 | Actionable PGx | ||
CYP2D6 | clozapine | 2626 | N05AH02 | B/C | Provisional | Actionable PGx | |||
SLC28A3 | daunorubicin | 3109 | L01DB02 | B/C | Provisional | ||||
CYP2D6 | deutetrabenazine | 1876905 | B/C | Provisional | Actionable PGx | ||||
CYP2D6 | dextromethorphan | 3289 | R05DA09 | B/C | Provisional | 3 | |||
CYP2C19 | diazepam | 3322 | N05BA01 | B/C | Provisional | 3 | Actionable PGx | ||
UGT1A1 | dolutegravir | 1433868 | B/C | Provisional | Actionable PGx | ||||
CYP2D6 | donepezil | 135447 | N06DA02 | B/C | Provisional | 3 | Actionable PGx | ||
SLC28A3 | doxorubicin | 3639 | L01DB01 | B/C | Provisional | ||||
CYP2C9 | dronabinol | 224925 | A04AD10 | B/C | Provisional | Actionable PGx | |||
SLCO1B1 | elagolix | 2049846 | B/C | Provisional | Actionable PGx | ||||
CYP2C9 | erdafitinib | 2123125 | B/C | Provisional | Actionable PGx | ||||
SLC6A4 | escitalopram | 321988 | N06AB10 | B/C | Provisional | 3 | |||
CYP2D6 | flecainide | 4441 | C01BC04 | B/C | Provisional | 1A | |||
CYP2D6 | gefitinib | 328134 | L01XE02 | B/C | Provisional | 3 | Actionable PGx | ||
CYP2D6 | haloperidol | 5093 | N05AD01 | B/C | Provisional | 1A | |||
CYP2D6 | iloperidone | 73178 | B/C | Provisional | 3 | Actionable PGx | |||
CYP2D6 | labetalol | 6185 | C07AG01 | B/C | Provisional | ||||
HLA-DRB1 | lapatinib | 480167 | L01XE07 | B/C | Provisional | 3 | Actionable PGx | ||
CYP2C9 | lesinurad | 1731031 | B/C | Provisional | Actionable PGx | ||||
G6PD | lidocaine | 6387 | C01BB01, C05AD01, D04AB01, N01BB02, R02AD02, S01HA07, S02DA01 | B/C | Provisional | ||||
MTHFR | l-methylfolate | 1025342 | B/C | Provisional | 3 | ||||
CYP2D6 | lofexidine | 28863 | N07BC04 | B/C | Provisional | Actionable PGx | |||
CYP2D6 | meclizine | 6676 | R06AE05 | B/C | Provisional | Actionable PGx | |||
CYP2D6 | metoclopramide | 6915 | A03FA01 | B/C | Provisional | Actionable PGx | |||
ADRB1 | metoprolol | 6918 | C07AB02 | B/C | Provisional | 3 | |||
CYP2D6 | metoprolol | 6918 | C07AB02 | B/C | Provisional | 1A | Informative PGx | ||
GRK5 | metoprolol | 6918 | C07AB02 | B/C | Provisional | ||||
CYP2D6 | mirabegron | 1300786 | B/C | Provisional | Actionable PGx | ||||
CYP2D6 | mirtazapine | 15996 | N06AX11 | B/C | Provisional | 2A | |||
BCHE | mivacurium | 30077 | M03AC | B/C | Provisional | ||||
CYP2D6 | nebivolol | 31555 | C07AB12 | B/C | Provisional | Informative PGx | |||
CYP2B6 | nevirapine | 53654 | J05AG01 | B/C | Provisional | 2A | |||
UGT1A1 | nilotinib | 662281 | L01XE08 | B/C | Provisional | 3 | Actionable PGx | ||
HLA-B | pazopanib | 714438 | L01XE | B/C | Provisional | Actionable PGx | |||
UGT1A1 | pazopanib | 714438 | L01XE | B/C | Provisional | 3 | Actionable PGx | ||
CYP2D6 | perphenazine | 8076 | N05AB03 | B/C | Provisional | Actionable PGx | |||
NAT2 | procainamide | 8700 | C01BA02 | B/C | Provisional | Informative PGx | |||
CYP2D6 | propafenone | 8754 | C01BC03 | B/C | Provisional | 1A | Actionable PGx | ||
CYP2D6 | propranolol | 8787 | C07AA05 | B/C | Provisional | 4 | Informative PGx | ||
CYP2D6 | protriptyline | 8886 | N06AA11 | B/C | Provisional | Actionable PGx | |||
UGT1A1 | raltegravir | 719872 | B/C | Provisional | Informative PGx | ||||
BCHE | succinylcholine | 10154 | M03AB01 | B/C | Provisional | 3 | Actionable PGx | ||
NAT2 | sulfamethoxazole / trimethoprim | 10831 | NA | B/C | Provisional | 3 | Actionable PGx | ||
NAT2 | sulfasalazine | 9524 | A07EC01 | B/C | Provisional | Actionable PGx | |||
CYP2D6 | tamsulosin | 77492 | G04CA02 | B/C | Provisional | Actionable PGx | |||
CYP2D6 | thioridazine | 10502 | N05AC02 | B/C | Provisional | 3 | Actionable PGx | ||
CYP2D6 | timolol | 10600 | C07AA06, S01ED01 | B/C | Provisional | 3 | |||
CYP2D6 | valbenazine | 1918219 | B/C | Provisional | Actionable PGx | ||||
CYP2D6 | zuclopenthixol | 114176 | N05AF05 | B/C | Provisional | 1A | |||
CYP2C9 | aceclofenac | 16689 | M01AB16 | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ | C | Final | 32189324 | ||
TNF | adalimumab | 327361 | L04AB04 | C | Provisional | ||||
COMT | alfentanil | 480 | N01AH02 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 33387367 | ||
OPRM1 | alfentanil | 480 | N01AH02 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 3 | 33387367 | |
HLA-C | allopurinol | 519 | M04AA01, M04AA51 | C | Provisional | 2B | |||
G6PD | aminosalicylic acid | 7833 | J04AA01 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | 36049896 | ||
MC4R | amisulpride | 46303 | N05AL05 | C | Provisional | 3 | |||
MC4R | aripiprazole | 89013 | N05AX12 | C | Provisional | 3 | |||
CYP2C9 | aspirin | 1191 | A01AD05, B01AC06, B01AC56, C10BX01, C10BX02, C10BX04, C10BX05, C10BX06, C10BX08, M01BA03, N02BA01, N02BA51, N02BA71 | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ | C | Final | 32189324 | ||
G6PD | aspirin | 1191 | A01AD05, B01AC06, B01AC56, C10BX01, C10BX02, C10BX04, C10BX05, C10BX06, C10BX08, M01BA03, N02BA01, N02BA51, N02BA71 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | 3 | 36049896 | |
HLA-DPB1 | aspirin | 1191 | A01AD05, B01AC06, B01AC56, C10BX01, C10BX02, C10BX04, C10BX05, C10BX06, C10BX08, M01BA03, N02BA01, N02BA51, N02BA71 | C | Provisional | 2B | |||
CFTR | ataluren | M09AX03 | C | Provisional | 3 | ||||
COMT | buprenorphine | 1819 | N02AE01, N07BC01 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 3 | 33387367 | |
OPRM1 | buprenorphine | 1819 | N02AE01, N07BC01 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 3 | 33387367 | |
HLA-B | carbimazole | 2020 | H03BB01 | C | Provisional | 3 | |||
MTHFR | carboplatin | 40048 | L01XA02 | C | Provisional | 3 | |||
G6PD | chloramphenicol | 2348 | D06AX02, D10AF03, G01AA05, J01BA01, S01AA01, S02AA01, S03AA08 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | 3 | 36049896 | |
G6PD | chloroquine | 2393 | P01BA01 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | 4 | Actionable PGx | 36049896 |
G6PD | chlorpropamide | 2404 | A10BB02 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | Actionable PGx | 36049896 | |
G6PD | ciprofloxacin | 2551 | J01MA02, S01AE03, S02AA15, S03AA07 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | 3 | 36049896 | |
COMT | citalopram | 2556 | N06AB04 | C | Provisional | ||||
GRIK4 | citalopram | 2556 | N06AB04 | C | Provisional | ||||
HTR2A | citalopram | 2556 | N06AB04 | C | Provisional | 3 | |||
CES1 | clopidogrel | 32968 | B01AC04 | C | Provisional | 2B | |||
HTR2C | clozapine | 2626 | N05AH02 | C | Provisional | 3 | |||
MC4R | clozapine | 2626 | N05AH02 | C | Provisional | 3 | |||
COMT | codeine | 2670 | R05DA04, N02AA59, N02AA79 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 33387367 | ||
OPRM1 | codeine | 2670 | R05DA04, N02AA59, N02AA79 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 3 | 33387367 | |
CYP3A5 | cyclosporine | 3008 | L04AD01, S01XA18 | C | Provisional | 3 | |||
G6PD | dabrafenib | 1424911 | NA | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | Actionable PGx | 36049896 | |
HLA-B | dapsone | 3108 | D10AX05, J04BA02 | C | Provisional | 2A | |||
CYP2D6 | darifenacin | 136198 | G04BD10 | C | Provisional | Actionable PGx | |||
CYP2C8 | diclofenac | 3355 | D11AX18, M01AB05, M02AA15, S01BC03 | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ | C | Final | 3 | 32189324 | |
CYP2C9 | diclofenac | 3355 | D11AX18, M01AB05, M02AA15, S01BC03 | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ | C | Final | 3 | 32189324 | |
ABCB1 | digoxin | 3407 | C01AA05 | C | Provisional | 3 | |||
G6PD | dimercaprol | 3445 | V03AB09 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | 3 | 36049896 | |
CYP2D6 | dolasetron | 68091 | A04AA04 | C | Provisional | 4 | |||
G6PD | doxorubicin | 3639 | L01DB01 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | 36049896 | ||
CYP2D6 | duloxetine | 72625 | N06AX21 | C | Provisional | Actionable PGx | |||
F5 | eltrombopag | 711942 | B02BX | C | Provisional | Actionable PGx | |||
COMT | escitalopram | 321988 | N06AB10 | C | Provisional | ||||
GRIK4 | escitalopram | 321988 | N06AB10 | C | Provisional | ||||
CYP2C19 | esomeprazole | 283742 | A02BC05 | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ | C | Final | 3 | Actionable PGx | 32770672 |
TNF | etanercept | 214555 | L04AB01 | C | Provisional | 2B | |||
ABCB1 | fentanyl | 4337 | N01AH01, N02AB03 | C | Provisional | 3 | |||
COMT | fentanyl | 4337 | N01AH01, N02AB03 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 3 | 33387367 | |
OPRM1 | fentanyl | 4337 | N01AH01, N02AB03 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 3 | 33387367 | |
CYP2D6 | fesoterodine | 797195 | G04BD11 | C | Provisional | Actionable PGx | |||
CYP2C19 | flibanserin | 1665509 | C | Provisional | Actionable PGx | ||||
CYP2C9 | flibanserin | 1665509 | C | Provisional | Actionable PGx | ||||
CYP2D6 | flibanserin | 1665509 | C | Provisional | Actionable PGx | ||||
CYP2D6 | fluoxetine | 4493 | N06AB03 | C | Provisional | 3 | Informative PGx | ||
GRIK4 | fluoxetine | 4493 | N06AB03 | C | Provisional | ||||
G6PD | furazolidone | 4601 | G01AX06 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | 36049896 | ||
CYP2D6 | galantamine | 4637 | N06DA04 | C | Provisional | 3 | Informative PGx | ||
G6PD | gliclazide | 4816 | A10BB09 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | 36049896 | ||
G6PD | glimepiride | 25789 | A10BB12 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | Actionable PGx | ||
G6PD | glipizide | 4821 | A10BB07 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | Actionable PGx | 36049896 | |
G6PD | glyburide | 4815 | A10BB01 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | 3 | Actionable PGx | 36049896 |
MC4R | haloperidol | 5093 | N05AD01 | C | Provisional | 3 | |||
F5 | hormonal contraceptives for systemic use | G03A | C | Provisional | 1A | ||||
COMT | hydrocodone | 5489 | R05DA03 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 33387367 | ||
OPRM1 | hydrocodone | 5489 | R05DA03 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 3 | 33387367 | |
COMT | hydromorphone | 3423 | N02AA03 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 33387367 | ||
OPRM1 | hydromorphone | 3423 | N02AA03 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 33387367 | ||
G6PD | hydroxychloroquine | 5521 | P01BA02 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | Actionable PGx | 36049896 | |
CYP2C8 | ibuprofen | 5640 | C01EB16, G02CC01, M01AE01, M02AA13 | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ | C | Final | 3 | 32189324 | |
CYP2C9 | indomethacin | 5781 | C01EB03 | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ | C | Final | 3 | 32189324 | |
TNF | infliximab | 191831 | L04AB02 | C | Provisional | 3 | |||
NAT2 | isoniazid | 6038 | J04AC01 | C | Provisional | 1B | |||
HLA-DQA1 | lapatinib | 480167 | L01XE07 | C | Provisional | 3 | Actionable PGx | ||
COMT | levomethadone | 236913 | N07BC05 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 33387367 | ||
OPRM1 | levomethadone | 236913 | N07BC05 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 33387367 | ||
CYP2C9 | lumiracoxib | M01AH06 | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ | C | Final | 32189324 | |||
G6PD | mafenide | 6572 | NA | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | Actionable PGx | 36049896 | |
G6PD | mepacrine | 9061 | P01AX05 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | 36049896 | ||
G6PD | mesalazine | 52582 | A07EC02 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | 36049896 | ||
COMT | methadone | 6813 | N07BC02 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 3 | 33387367 | |
CYP2D6 | methadone | 6813 | N07BC02 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 3 | 33387367 | |
OPRM1 | methadone | 6813 | N07BC02 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 3 | 33387367 | |
HLA-B | methazolamide | 6826 | S01EC05 | C | Provisional | 2A | |||
HLA-C | methazolamide | 6826 | S01EC05 | C | Provisional | 2B | |||
HLA-B | methimazole | 6835 | H03BB02 | C | Provisional | 3 | |||
ABCB1 | methotrexate | 6851 | L01BA01, L04AX03 | C | Provisional | 3 | |||
MTHFR | methotrexate | 6851 | L01BA01, L04AX03 | C | Provisional | 2A | |||
SLCO1B1 | methotrexate | 6851 | L01BA01, L04AX03 | C | Provisional | 3 | |||
CYP2D6 | methylphenidate | 6901 | N06BA04 | C | Provisional | 3 | |||
CYP2D6 | modafinil | 30125 | N06BA07 | C | Provisional | Actionable PGx | |||
COMT | morphine | 7052 | N02AA01 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 3 | 33387367 | |
OPRM1 | morphine | 7052 | N02AA01 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 3 | 33387367 | |
CYP2C9 | nabumetone | 31448 | M01AX01 | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ | C | Final | 32189324 | ||
G6PD | nalidixic acid | 7240 | J01MB02 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | Actionable PGx | 36049896 | |
OPRM1 | naloxone | 7242 | V03AB15 | C | Provisional | 3 | |||
COMT | naltrexone | 7243 | N07BB04 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 33387367 | ||
OPRM1 | naltrexone | 7243 | N07BB04 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 4 | 33387367 | |
CYP2C9 | naproxen | 7258 | M01AE56 | https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/ | C | Final | 3 | 32189324 | |
ABCB1 | nevirapine | 53654 | J05AG01 | C | Provisional | 3 | |||
HLA-B | nevirapine | 53654 | J05AG01 | C | Provisional | 3 | |||
HLA-DRB1 | nevirapine | 53654 | J05AG01 | C | Provisional | 2B | |||
G6PD | nicorandil | 31748 | C01DX16 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | 36049896 | ||
G6PD | nitrofural | 7455 | B05CA03, D08AF01, D09AA03, P01CC02, S01AX04, S02AA02 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | 36049896 | ||
G6PD | norfloxacin | 7517 | J01MA06, S01AE02 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | Actionable PGx | 36049896 | |
G6PD | ofloxacin | 7623 | J01MA01, S01AE01, S02AA16 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | 36049896 | ||
HTR2C | olanzapine | 61381 | N05AH03 | C | Provisional | 3 | |||
MC4R | olanzapine | 61381 | N05AH03 | C | Provisional | 3 | |||
HLA-A | oxcarbazepine | 32624 | N03AF02 | https://cpicpgx.org/guidelines/guideline-for-carbamazepine-and-hla-b/ | C | Final | 3 | 29392710 | |
COMT | oxycodone | 7804 | N02AA05 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 3 | 33387367 | |
CYP2D6 | oxycodone | 7804 | N02AA05 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 2A | 33387367 | |
OPRM1 | oxycodone | 7804 | N02AA05 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 3 | 33387367 | |
MC4R | paliperidone | 679314 | N05AX13 | C | Provisional | 3 | |||
CYP2D6 | palonosetron | 70561 | A04AA05 | C | Provisional | Informative PGx | |||
GRIK4 | paroxetine | 32937 | N06AB05 | C | Provisional | ||||
G6PD | phenazopyridine | 8120 | G04BX06 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | 3 | 36049896 | |
G6PD | probenecid | 8698 | M04AB01 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | Actionable PGx | 36049896 | |
HLA-B | propylthiouracil | 8794 | H03BA02 | C | Provisional | 3 | |||
MC4R | quetiapine | 51272 | N05AH04 | C | Provisional | 3 | |||
CYP2D6 | quinidine | 9068 | C01BA01 | C | Provisional | Informative PGx | |||
CYP2D6 | quinine | 9071 | P01BC01 | C | Provisional | Actionable PGx | |||
G6PD | quinine | 9071 | P01BC01 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | Actionable PGx | 36049896 | |
CYP2C19 | rabeprazole | 114979 | A02BC04 | https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/ | C | Final | 2A | Actionable PGx | 32770672 |
COMT | remifentanil | 73032 | N01AH06 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 3 | 33387367 | |
OPRM1 | remifentanil | 73032 | N01AH06 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 3 | 33387367 | |
DRD2 | risperidone | 35636 | N05AX08 | C | Provisional | 3 | |||
HTR2C | risperidone | 35636 | N05AX08 | C | Provisional | 3 | |||
MC4R | risperidone | 35636 | N05AX08 | C | Provisional | 3 | |||
CYP2C8 | rosiglitazone | 84108 | A10BG02 | C | Provisional | 3 | |||
CYP2D6 | sertraline | 36437 | N06AB06 | C | Provisional | 3 | |||
GRIK4 | sertraline | 36437 | N06AB06 | C | Provisional | ||||
ABCB1 | simvastatin | 36567 | C10AA01, C10BA02, C10BX04, A10BH51, C10BA04, C10BX01 | C | Provisional | 3 | |||
CYP3A5 | sirolimus | 35302 | L04AA10 | C | Provisional | 3 | |||
G6PD | sodium nitrite | 9894 | NA | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | Actionable PGx | 36049896 | |
COMT | sufentanil | 56795 | N01AH03 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 3 | 33387367 | |
OPRM1 | sufentanil | 56795 | N01AH03 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 3 | 33387367 | |
G6PD | sulfacetamide | 10169 | D10AF06, S01AB04 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | 36049896 | ||
G6PD | sulfadiazine | 10171 | J01EC02 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | Actionable PGx | 36049896 | |
G6PD | sulfadimidine | 10178 | J01EB03 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | 36049896 | ||
G6PD | sulfamethoxazole / trimethoprim | 10831 | NA | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | 4 | Actionable PGx | 36049896 |
G6PD | sulfanilamide | 10184 | D06BA05, J01EB06 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | 36049896 | ||
G6PD | sulfasalazine | 9524 | A07EC01 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | 3 | Actionable PGx | 36049896 |
G6PD | sulfisoxazole | 10207 | J01EB05, S01AB02 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | 36049896 | ||
CYP3A4 | tacrolimus | 42316 | D11AH01, L04AD02 | C | Provisional | 1B | |||
DPYD | tegafur | 4582 | L01BC03, L01BC53 | https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/ | C | Final | 1A | 23988873;29152729 | |
CYP2D6 | terbinafine | 37801 | D01AE15, D01BA02 | C | Provisional | Informative PGx | |||
G6PD | tolazamide | 10633 | A10BB05 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | 36049896 | ||
G6PD | tolbutamide | 10635 | A10BB03, V04CA01 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | 36049896 | ||
CYP2D6 | tolterodine | 119565 | G04BD07 | C | Provisional | 3 | Actionable PGx | ||
COMT | tramadol | 10689 | N02AX02 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 3 | 33387367 | |
OPRM1 | tramadol | 10689 | N02AX02 | https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/ | C | Final | 3 | 33387367 | |
G6PD | trametinib | 1425099 | NA | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | 36049896 | ||
GRIK4 | venlafaxine | 39786 | N06AX16 | C | Provisional | ||||
G6PD | vitamin c | 1151 | G01AD03, S01XA15 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | 36049896 | ||
G6PD | vitamin k | 11258 | B02BA | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C | Final | 36049896 | ||
MC4R | ziprasidone | 115698 | N05AE04 | C | Provisional | ||||
ITPA | interferon alfa-2b, recombinant | 5880 | L03AB05 | C/D | Provisional | 3 | |||
CYP3A5 | midazolam | 6960 | N05CD08 | C/D | Provisional | 3 | |||
G6PD | moxifloxacin | 139462 | J01MA14, S01AE07 | https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/ | C/D | Final | 36049896 | ||
COMT | nicotine | 7407 | N07BA01 | C/D | Provisional | 3 | |||
ABCB1 | ondansetron | 26225 | A04AA01 | C/D | Provisional | 3 | |||
UGT2B15 | oxazepam | 7781 | N05BA04 | C/D | Provisional | 3 | |||
FDPS | alendronate | 46041 | M05BA04 | D | Provisional | ||||
GP1BA | aspirin | 1191 | A01AD05, B01AC06, B01AC56, C10BX01, C10BX02, C10BX04, C10BX05, C10BX06, C10BX08, M01BA03, N02BA01, N02BA51, N02BA71 | D | Provisional | 3 | |||
LTC4S | aspirin | 1191 | A01AD05, B01AC06, B01AC56, C10BX01, C10BX02, C10BX04, C10BX05, C10BX06, C10BX08, M01BA03, N02BA01, N02BA51, N02BA71 | D | Provisional | 3 | |||
PTGS1 | aspirin | 1191 | A01AD05, B01AC06, B01AC56, C10BX01, C10BX02, C10BX04, C10BX05, C10BX06, C10BX08, M01BA03, N02BA01, N02BA51, N02BA71 | D | Provisional | 3 | |||
APOE | atorvastatin | 83367 | C10AA05 | D | Provisional | 2B | |||
CETP | atorvastatin | 83367 | C10AA05 | D | Provisional | 4 | |||
COQ2 | atorvastatin | 83367 | C10AA05 | D | Provisional | 3 | |||
KIF6 | atorvastatin | 83367 | C10AA05 | D | Provisional | 3 | |||
LDLR | atorvastatin | 83367 | C10AA05 | D | Provisional | Informative PGx | |||
LPA | atorvastatin | 83367 | C10AA05 | D | Provisional | ||||
CRHR1 | budesonide | 19831 | A07EA06, D07AC09, R01AD05, R03BA02 | D | Provisional | ||||
ADORA2A | caffeine | 1886 | N06BC01 | D | Provisional | 3 | |||
TYMS | capecitabine | 194000 | L01BC06 | D | Provisional | 3 | |||
ACE | captopril | 1998 | C09AA01 | D | Provisional | 2A | |||
EPHX1 | carbamazepine | 2002 | N03AF01 | D | Provisional | 3 | |||
CETP | cerivastatin | 596723 | C10AA06 | D | Provisional | ||||
LPA | cerivastatin | 596723 | C10AA06 | D | Provisional | ||||
EGF | cetuximab | 318341 | L01XC06 | D | Provisional | 3 | |||
ACYP2 | cisplatin | 2555 | L01XA01 | D | Provisional | 3 | |||
ERCC1 | cisplatin | 2555 | L01XA01 | D | Provisional | 3 | |||
GSTM1 | cisplatin | 2555 | L01XA01 | D | Provisional | 3 | |||
NQO1 | cisplatin | 2555 | L01XA01 | D | Provisional | ||||
XPC | cisplatin | 2555 | L01XA01 | D | Provisional | 3 | |||
FKBP5 | citalopram | 2556 | N06AB04 | D | Provisional | 3 | |||
ANKK1 | clozapine | 2626 | N05AH02 | D | Provisional | ||||
GSTP1 | cyclophosphamide | 3002 | L01AA01 | D | Provisional | 3 | |||
NQO1 | cyclophosphamide | 3002 | L01AA01 | D | Provisional | 3 | |||
SOD2 | cyclophosphamide | 3002 | L01AA01 | D | Provisional | 3 | |||
CBR3 | daunorubicin | 3109 | L01DB02 | D | Provisional | ||||
HAS3 | daunorubicin | 3109 | L01DB02 | D | Provisional | ||||
CBR3 | doxorubicin | 3639 | L01DB01 | D | Provisional | 3 | |||
HAS3 | doxorubicin | 3639 | L01DB01 | D | Provisional | ||||
NQO1 | doxorubicin | 3639 | L01DB01 | D | Provisional | ||||
SERPINC1 | eltrombopag | 711942 | B02BX | D | Provisional | Actionable PGx | |||
CBR3 | epirubicin | 3995 | L01DB03 | D | Provisional | 3 | |||
GSTP1 | epirubicin | 3995 | L01DB03 | D | Provisional | 3 | |||
HAS3 | epirubicin | 3995 | L01DB03 | D | Provisional | ||||
NQO1 | epirubicin | 3995 | L01DB03 | D | Provisional | 3 | |||
DYNC2H1 | etoposide | 4179 | L01CB01 | D | Provisional | 3 | |||
GSTP1 | fluorouracil | 4492 | L01BC02, L01BC52 | D | Provisional | 3 | |||
NQO1 | fluorouracil | 4492 | L01BC02, L01BC52 | D | Provisional | 3 | |||
TYMS | fluorouracil | 4492 | L01BC02, L01BC52 | D | Provisional | 3 | |||
UMPS | fluorouracil | 4492 | L01BC02, L01BC52 | D | Provisional | 3 | |||
FKBP5 | fluoxetine | 4493 | N06AB03 | D | Provisional | 3 | |||
CRHR1 | fluticasone propionate | 50121 | D07AC17, R01AD08, R03BA05 | D | Provisional | ||||
CRHR1 | fluticasone/salmeterol | 284635 | D | Provisional | |||||
CETP | fluvastatin | 41127 | C10AA04 | D | Provisional | 3 | |||
LPA | fluvastatin | 41127 | C10AA04 | D | Provisional | ||||
ADD1 | furosemide | 4603 | C03CA01 | D | Provisional | 3 | |||
NT5C2 | gemcitabine | 12574 | L01BC05 | D | Provisional | 3 | |||
NEDD4L | hydrochlorothiazide | 5487 | C03AA03, C03AB03, C09DX01, C09DX03, C09XA52, C03EA01, C03AX01, G01AE10, C09XA54 | D | Provisional | 3 | |||
PRKCA | hydrochlorothiazide | 5487 | C03AA03, C03AB03, C09DX01, C09DX03, C09XA52, C03EA01, C03AX01, G01AE10, C09XA54 | D | Provisional | 3 | |||
YEATS4 | hydrochlorothiazide | 5487 | C03AA03, C03AB03, C09DX01, C09DX03, C09XA52, C03EA01, C03AX01, G01AE10, C09XA54 | D | Provisional | 3 | |||
CBR3 | idarubicin | 5650 | L01DB06 | D | Provisional | ||||
HAS3 | idarubicin | 5650 | L01DB06 | D | Provisional | ||||
C8orf34 | irinotecan | 51499 | L01XX19 | D | Provisional | 3 | |||
SEMA3C | irinotecan | 51499 | L01XX19 | D | Provisional | 3 | |||
UGT1A4 | lamotrigine | 28439 | N03AX09 | D | Provisional | 3 | |||
PTGFR | latanoprost | 43611 | S01EE01 | D | Provisional | 3 | |||
C11orf65 | metformin | 6809 | A10BA02 | D | Provisional | 4 | |||
ATIC | methotrexate | 6851 | L01BA01, L04AX03 | D | Provisional | 2B | |||
MTRR | methotrexate | 6851 | L01BA01, L04AX03 | D | Provisional | 3 | |||
CYB5R1 | metoclopramide | 6915 | A03FA01 | D | Provisional | Actionable PGx | |||
CYB5R2 | metoclopramide | 6915 | A03FA01 | D | Provisional | Actionable PGx | |||
CYB5R3 | metoclopramide | 6915 | A03FA01 | D | Provisional | Actionable PGx | |||
CYB5R4 | metoclopramide | 6915 | A03FA01 | D | Provisional | Actionable PGx | |||
FKBP5 | mirtazapine | 15996 | N06AX11 | D | Provisional | 3 | |||
CCHCR1 | nevirapine | 53654 | J05AG01 | D | Provisional | 3 | |||
CHRNA3 | nicotine | 7407 | N07BA01 | D | Provisional | 3 | |||
ANKK1 | olanzapine | 61381 | N05AH03 | D | Provisional | 3 | |||
GSTM1 | oxaliplatin | 32592 | L01XA03 | D | Provisional | 3 | |||
GSTP1 | oxaliplatin | 32592 | L01XA03 | D | Provisional | 3 | |||
FKBP5 | paroxetine | 32937 | N06AB05 | D | Provisional | 3 | |||
HTR1A | paroxetine | 32937 | N06AB05 | D | Provisional | 3 | |||
VDR | peginterferon alfa-2b | 253453 | L03AB10, L03AB60 | D | Provisional | 3 | |||
CETP | pravastatin | 42463 | C10AA03 | D | Provisional | 3 | |||
HMGCR | pravastatin | 42463 | C10AA03 | D | Provisional | 3 | |||
KIF6 | pravastatin | 42463 | C10AA03 | D | Provisional | 2B | |||
LPA | pravastatin | 42463 | C10AA03 | D | Provisional | ||||
FDPS | raloxifene | 72143 | G03XC01 | D | Provisional | ||||
VDR | ribavirin | 9344 | J05AB04 | D | Provisional | 3 | |||
FDPS | risedronate | 73056 | M05BA07 | D | Provisional | ||||
ANKK1 | risperidone | 35636 | N05AX08 | D | Provisional | 3 | |||
FCGR3A | rituximab | 121191 | L01XC02 | D | Provisional | 2B | |||
COQ2 | rosuvastatin | 301542 | C10AA07 | D | Provisional | 3 | |||
LPA | rosuvastatin | 301542 | C10AA07 | D | Provisional | 3 | |||
ADRB2 | salbutamol | 435 | R03AC02, R03CC02 | D | Provisional | 3 | |||
COL22A1 | salbutamol | 435 | R03AC02, R03CC02 | D | Provisional | 3 | |||
CRHR2 | salbutamol | 435 | R03AC02, R03CC02 | D | Provisional | 3 | |||
ADRB2 | salmeterol | 36117 | R03AC12 | D | Provisional | 2A | |||
GNB3 | sildenafil | 136411 | G04BE03 | D | Provisional | 3 | |||
CETP | simvastatin | 36567 | C10AA01, C10BA02, C10BX04, A10BH51, C10BA04, C10BX01 | D | Provisional | 3 | |||
HMGCR | simvastatin | 36567 | C10AA01, C10BA02, C10BX04, A10BH51, C10BA04, C10BX01 | D | Provisional | 3 | |||
LPA | simvastatin | 36567 | C10AA01, C10BA02, C10BX04, A10BH51, C10BA04, C10BX01 | D | Provisional | ||||
ADD1 | spironolactone | 9997 | C03DA01 | D | Provisional | 3 | |||
ABCC4 | tenofovir | 117466 | J05AF | D | Provisional | 3 | |||
CRHR1 | triamcinolone | 10759 | A01AC01, C05AA12, D07AB09, D07XB02, H02AB08, R01AD11, R03BA06, S01BA05 | D | Provisional | ||||
FKBP5 | venlafaxine | 39786 | N06AX16 | D | Provisional | 3 | |||
CALU | warfarin | 11289 | B01AA03 | D | Provisional | 3 | |||
GGCX | warfarin | 11289 | B01AA03 | D | Provisional | 3 | |||
PROC | warfarin | 11289 | B01AA03 | D | Provisional | Actionable PGx | |||
PROS1 | warfarin | 11289 | B01AA03 | D | Provisional | Actionable PGx |